Inventor · disambiguated record
Robin Larouche-Gauthier
Also filed as: LAROUCHE-GAUTHIER ROBIN
10 granted patents·7 pending applications·5 citations·filing 2013–2024
80Inventor score
Top patents by PatentIndex Score
17 records- 0187US10710994B2Oxadiazole transient receptor potential channel inhibitorsGENENTECH INC·Filed 2019·Granted Jul 14, 2020·3 cites·38 claims
- 0282US2025122184A1Oxadiazole transient receptor potential channel inhibitorsGENENTECH INC·Filed 2024·Application pending·0 cites
- 0379US11124527B2Compounds for the modulation of Myc activitySYROS PHARMACEUTICALS INC·Filed 2016·Granted Sep 21, 2021·2 cites·30 claims
- 0477US12202824B2Oxadiazole transient receptor potential channel inhibitorsGENENTECH INC·Filed 2022·Granted Jan 21, 2025·0 cites·17 claims
- 0571US2023144106A1Compounds for the modulation of myc activitySYROS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0670US2025230147A1Lactams as cbl-b inhibitorsGENENTECH INC·Filed 2024·Application pending·0 cites
- 0768US11655245B2Oxadiazole transient receptor potential channel inhibitorsGENENTECH INC·Filed 2020·Granted May 23, 2023·0 cites·48 claims
- 0863US11753418B2Compounds for the modulation of Myc activitySYROS PHARMACEUTICALS INC·Filed 2021·Granted Sep 12, 2023·0 cites·30 claims
- 0962US2021188833A1Compounds for the modulation of myc activitySYROS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1060US2023079990A1Lactams as cbl-b inhibitorsGENENTECH INC·Filed 2022·Application pending·0 cites
- 1157US12187709B2Lactams as CBL-B inhibitors selective over C-CBLGENENTECH INC·Filed 2022·Granted Jan 7, 2025·0 cites·20 claims
- 1255US10787444B2Compounds for the modulation of myc activitySYROS PHARMACEUTICALS INC·Filed 2016·Granted Sep 29, 2020·0 cites·25 claims
- 1352US10913742B2Oxadiazolones as transient receptor potential channel inhibitorsGENENTECH INC·Filed 2019·Granted Feb 9, 2021·0 cites·13 claims
- 1452US2024300927A1Amides as cbl-b inhibitorsGENENTECH INC·Filed 2022·Application pending·0 cites
- 1548US10711004B2Oxadiazole transient receptor potential channel inhibitorsGENENTECH INC·Filed 2019·Granted Jul 14, 2020·0 cites·23 claims
- 1646US11274103B2Compounds for the modulation of MYC activitySYROS PHARMACEUTICALS INC·Filed 2017·Granted Mar 15, 2022·0 cites·24 claims
- 1738US2014371285A1Therapeutic compounds and related methods of useSPROTT KEVIN·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robin Larouche-Gauthier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →